---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-040230"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T15:13:21.957898+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Enanta stockholders approve 800k-share increase to 2019 equity plan; re-elect directors

## Summary
- Stockholders approved amendment to 2019 Equity Incentive Plan, adding 800,000 shares (11,435,985 for, 4,085,303 against).
- Mark G. Foletta and Lesley Russell re-elected as Class III directors until 2028 annual meeting.
- Advisory vote on executive compensation passed (14,516,861 for, 1,039,888 against); frequency set to annual.
- PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2025 (17,740,127 for, 72,357 against).

## SEC filing metadata
- accession: 0000950170-25-040230
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000095017025040230/0000950170-25-040230-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000095017025040230/enta-20250313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-040230
- JSON: https://secwatch.observer/filing/0000950170-25-040230.json
- Plain text: https://secwatch.observer/filing/0000950170-25-040230.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.